v3.26.1
Equity (Tables)
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of stock based compensation expense Share-based compensation expense was as follows:
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Restricted stock units (“RSUs”):
Pre-tax compensation expense$6 $5 $12 $12 
Income tax effect— (1)(1)(2)
RSUs, net of income taxes6 4 11 10 
Performance shares and other share-based awards:
Pre-tax compensation expense2 4 6 9 
Income tax effect1 — — — 
Performance shares and other share-based awards, net of income taxes3 4 6 9 
Stock options:
Pre-tax compensation expense— 2 — 3 
Income tax effect— — — — 
Stock options, net of income taxes— 2 — 3 
Total share-based compensation:
Pre-tax compensation expense8 11 18 24 
Income tax effect1 (1)(1)(2)
Total share-based compensation expense, net of income taxes$9 $10 $17 $22 
Schedule of restricted unit activity
RSU activity for year-to-date 2026 was as follows:
Number of
Restricted
Shares
(in thousands)		Weighted
Average
Fair Value
per Share
Non-vested as of December 31, 2025510$112.44 
Granted215115.69 
Vested(167)99.11 
Cancelled(24)117.81 
Non-vested as of June 30, 2026534$117.69 
Schedule of valuation assumptions for stock options We estimated the fair value of each option grant by using the Black-Scholes option-pricing model with the following assumptions for 2025:
Six Months Ended June 30, 2025
Expected life (in years)5.5
Risk-free interest rate4.1%
Expected volatility28.2%
Expected dividend yield2.5%
Schedule of stock option transactions
Stock option activity for year-to-date 2026 was as follows:
Number of Options
(in thousands)		Weighted Average Exercise Price per ShareAverage Remaining Contractual Term (in years)Aggregate Intrinsic Value
(in millions)
Outstanding as of December 31, 20251,269$105.75 5.3$13 
Granted—— 
Exercised(12)99.75 
Cancelled(15)121.85 
Outstanding as of June 30, 20261,242$105.61 4.8$3 
Exercisable as of June 30, 20261,106$103.47 4.4$3 
Schedule of additional information pertaining to stock option activity
Additional information pertaining to stock option activity was as follows:
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Weighted average grant date fair value of stock options granted (per share)$— $— $— $33.53 
Total intrinsic value of stock options exercised— 1 — 2 
Summary of net changes in accumulated other comprehensive loss A summary of accumulated other comprehensive loss for year-to-date 2026 and 2025 was as follows:
Cumulative Translation AdjustmentHedging ActivitiesPension and Postretirement AdjustmentAOCL
Balance as of December 31, 2025$(899)$(5)$(33)$(937)
Other comprehensive income before reclassification adjustments 109 (34)— 75 
Loss reclassified from AOCL— 7 — 7 
Tax effect— 7 — 7 
Net other comprehensive income (loss)109 (20)— 89 
Balance as of June 30, 2026$(790)$(25)$(33)$(848)
Cumulative Translation AdjustmentHedging ActivitiesPension and Postretirement AdjustmentAOCL
Balance as of December 31, 2024$(1,061)$4 $(29)$(1,086)
Other comprehensive income before reclassification adjustments 138 4 — 142 
(Income) reclassified from AOCL— (11)— (11)
Tax effect— (2)— (2)
Net other comprehensive income (loss)138 (5)— 133 
Balance as of June 30, 2025$(923)$(1)$(29)$(953)
Schedule of stockholders equity The following Condensed Consolidated Statements of Equity and Redeemable Equity present information about the dividends per share for common stock for the periods indicated:
Total EquityShare-based
Payments
Subject to
Redemption		Redeemable
Non-
Controlling
Interests
Preferred
Stock		Common
Stock		Additional
Paid-In
Capital		Treasury
Stock		Accumulated Other
Comprehensive
Loss		Retained
Earnings		Non-
Redeemable
Non-
Controlling
Interests
Balance as of December 31, 2025$— $1 $1,155 $(1,555)$(937)$5,610 $21 $64 $7 
Net income attributable to Ingredion— — — — — 142 — — — 
Net income attributable to non-controlling interests— — — — — — 2 — — 
Dividends declared, common stock ($0.82/share)
— — — — — (52)— — — 
Repurchases of common stock, net— — — (14)— — — — — 
Share-based compensation, net of issuance— — 7 16 — — — (23)— 
Purchases of non-controlling interests— — — — — — — — (7)
Other comprehensive income (loss)— — — — 10 — (1)— — 
Balance as of March 31, 2026$— $1 $1,162 $(1,553)$(927)$5,700 $22 $41 $— 
Net income attributable to Ingredion— — — — — 114 — — — 
Net income attributable to non-controlling interests— — — — — — 2 — — 
Dividends declared, common stock ($0.82/share)
— — — — — (53)— — — 
Dividends declared, non-controlling interests— — — — — — (2)— — 
Share-based compensation, net of issuance— — 1 — — — — 8 — 
Sale of business— — — — — — (23)— — 
Other comprehensive income— — — — 79 — 1 — — 
Balance as of June 30, 2026$— $1 $1,163 $(1,553)$(848)$5,761 $— $49 $— 
Total EquityShare-based
Payments
Subject to
Redemption		Redeemable
Non-
Controlling
Interests
Preferred
Stock		Common
Stock		Additional
Paid-In
Capital		Treasury
Stock		Accumulated Other
Comprehensive
Loss		Retained
Earnings		Non-
Redeemable
Non-
Controlling
Interests
Balance as of December 31, 2024$— $1 $1,152 $(1,355)$(1,086)$5,092 $19 $60 $7 
Net income attributable to Ingredion— — — — — 197 — — — 
Net income attributable to non-controlling interests— — — — — — 2 — — 
Dividends declared, common stock ($0.80/share)
— — — — — (53)— — — 
Repurchases of common stock, net— — — (55)— — — — — 
Share-based compensation, net of issuance— — 6 17 — — — (18)— 
Other comprehensive income— — — — 61 — — — 1 
Balance as of March 31, 2025$— $1 $1,158 $(1,393)$(1,025)$5,236 $21 $42 $8 
Net income attributable to Ingredion— — — — — 196 — — — 
Net income attributable to non-controlling interests— — — — — — 2 — — 
Dividends declared, common stock ($0.80/share)
— — — — — (52)— — — 
Dividends declared, non-controlling interests— — — — — — (2)— — 
Share-based compensation, net of issuance— — 2 2 — — — 9 — 
Other comprehensive income (loss)— — — — 72 — — — (1)
Balance as of June 30, 2025$— $1 $1,160 $(1,391)$(953)$5,380 $21 $51 $7 
Schedule of basic and diluted earnings per common share The following table presents information about the computation of basic and diluted earnings per common share (“EPS”):
Three Months Ended June 30, 2026Three Months Ended June 30, 2025
Net Income
Attributable
to Ingredion		Weighted
Average
Shares		Per
Share
Amount		Net Income
Attributable
to Ingredion		Weighted
Average
Shares		Per
Share
Amount
Basic EPS$114 63.3$1.80 $196 64.5$3.04 
Effect of Dilutive Securities (i)
0.61.1
Diluted EPS$114 63.9$1.78 $196 65.6$2.99 
Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Net Income
Attributable
to Ingredion		Weighted
Average
Shares		Per
Share
Amount		Net Income
Attributable
to Ingredion		Weighted
Average
Shares		Per
Share
Amount
Basic EPS$256 63.2$4.05 $393 64.5$6.09 
Effect of Dilutive Securities (i)
0.71.1
Diluted EPS$256 63.9$4.01 $393 65.6$5.99 
_________________
(i)Incremental shares from assumed exercise of dilutive stock options, vesting of dilutive stock options, and vesting of dilutive RSUs and other awards.